Orencia 125 (Abatacept PFS) 125mg

Orencia 125 (Abatacept) is a prescription medication in pre-filled syringe form, used to help manage immune responses. It contains 125mg of abatacept per syringe and is supplied in packs of four. Store between 2-8°C to maintain stability.

Strength

125mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

BMS

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Abatacept is commonly used to help reduce symptoms and slow the progression of certain autoimmune conditions by modulating the immune system. It is often prescribed for adults with moderate to severe rheumatoid arthritis or psoriatic arthritis when other treatments have not been effective. People often ask, 'what is Orencia 125 used for' to understand its role in managing chronic inflammatory conditions.

Side Effects

This medication works by targeting specific immune cells to help reduce inflammation and joint damage over time. Users may notice gradual improvements in mobility and daily functioning as the treatment progresses. Effects vary by individual and may take several weeks to become noticeable.

Precautions & Warnings

Keep Orencia 125 refrigerated at all times and protect it from light. Do not freeze or shake the pre-filled syringe. Always check the liquid for particles or discoloration before use. Dispose of used syringes properly according to local guidelines.

Avoid Interactions

Abatacept may interact with other medications that affect the immune system, such as TNF inhibitors or live vaccines. Combining it with certain immunosuppressants could increase the risk of infections. Always inform your healthcare provider about all medications you are taking before starting this treatment.

Frequently Asked Questions

Store Orencia 125 in the refrigerator between 2-8°C. Do not freeze or expose to extreme temperatures.

Consult your healthcare provider before using Orencia 125 if you currently have an infection or signs of illness.

Contact your healthcare provider for guidance if you miss a dose; do not take a double dose to catch up.

Yes, Orencia 125 contains abatacept, which is a biologic disease-modifying antirheumatic drug (DMARD).

Effects may vary; some users notice improvements within a few weeks, while others may take longer to see changes.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.